http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15582342
Outgoing Links
Predicate
Object
contentType
Journal Article|Research Support, N.I.H., Extramural
endingPage
1139
issn
2157-846X
issueIdentifier
12
pageRange
1134-1139
publicationName
Nature Biomedical Engineering
startingPage
1134
hasFundingAgency
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_73b9341bdb24165a703a74c90c424f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_31f2a543be149aa96cca75fad1a1e988
isSupportedBy
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0b8173f862386a85821235ce5a6baa60
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3fd58cccb5553adb45f43c2b1ffc1ed9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a1c524189177f3a09e5d6fb12a7e9185
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_69731bb36a4061fbaf74a48f03dfbd8c
bibliographicCitation
Jiang S, Zhang X, Yang Y, Hotez PJ, Du L. Neutralizing antibodies for the treatment of COVID-19. Nature Biomedical Engineering. 2020 Dec 08;4(12):1134–9. doi: 10.1038/s41551-020-00660-2.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be588f7cf69b5c1e25f4a994a9c37400
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_967528dffa4d981a05782bd57811f223
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bc8b41e3b647016d60d219d6192a450
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_250f860cade8e41dbe6e27a62a495304
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date
2020-12-08-04:00
^^<
http://www.w3.org/2001/XMLSchema#date
>
identifier
https://pubmed.ncbi.nlm.nih.gov/33293725
https://doi.org/10.1038/s41551-020-00660-2
https://pubmed.ncbi.nlm.nih.gov/PMC7891858
isPartOf
https://portal.issn.org/resource/ISSN/2157-846X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/45929
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title
Neutralizing antibodies for the treatment of COVID-19
discusses
http://id.nlm.nih.gov/mesh/M0534745
Total number of triples:
33
.